New England Private Wealth Advisors Has Increased Its Neogen (NEOG) Position; Aravt Global Lowered Its Cdk Global (CDK) Stake

June 19, 2018 - By Linda Rogers

Neogen Corporation (NASDAQ:NEOG) Logo

Aravt Global Llc decreased Cdk Global Inc (CDK) stake by 13.04% reported in 2018Q1 SEC filing. Aravt Global Llc sold 178,000 shares as Cdk Global Inc (CDK)’s stock declined 8.48%. The Aravt Global Llc holds 1.19 million shares with $75.19 million value, down from 1.37 million last quarter. Cdk Global Inc now has $8.42B valuation. The stock decreased 0.49% or $0.315 during the last trading session, reaching $63.975. About 316,473 shares traded. CDK Global, Inc. (NASDAQ:CDK) has risen 4.20% since June 19, 2017 and is uptrending. It has underperformed by 8.37% the S&P500. Some Historical CDK News: ; 15/05/2018 – Senator Investment Group Buys New 1.6% Position in CDK Global; 26/04/2018 – CDK GLOBAL INC CDK.O SEES FY 2018 GAAP SHR $2.67 TO $2.72; 16/04/2018 – Cyclacel Announces Results of Phase 1 Clinical Data for CDK Inhibitor CYC065; 30/05/2018 – CDK Global Closes Above 50-Day Moving Average: Technicals; 17/04/2018 – Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia; 26/04/2018 – CDK GLOBAL INC CDK.O – QTRLY REVENUES UP 4% TO $576.6 MILLION; 16/04/2018 – Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting; 20/03/2018 – Car Dealer Software Makers CDK, Auto/Mate Call Off Merger Due to FTC Opposition; 26/04/2018 – CDK Global 3Q Adj EPS 85c; 26/04/2018 – CDK Global Lowers 2018 Rev Guidance to Range of 2.5%-3% Growth From 3%-4%




New England Private Wealth Advisors Llc increased Neogen Corp (NEOG) stake by 33.33% reported in 2018Q1 SEC filing. New England Private Wealth Advisors Llc acquired 6,000 shares as Neogen Corp (NEOG)’s stock rose 22.25%. The New England Private Wealth Advisors Llc holds 24,000 shares with $1.61 million value, up from 18,000 last quarter. Neogen Corp now has $4.20B valuation. The stock decreased 0.52% or $0.43 during the last trading session, reaching $81.5. About 93,059 shares traded. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since June 19, 2017 and is uptrending. It has outperformed by 44.12% the S&P500. Some Historical NEOG News: ; 17/05/2018 – Consolidated Research: 2018 Summary Expectations for TrueCar, Roadrunner Transportation, Eldorado Gold, Neogen, Ashford Hospita; 19/04/2018 – Neogen names Donofrio VP of Food Safety R&D; 22/03/2018 – NEOGEN 3Q SPLIT ADJ. EPS 32C; 22/03/2018 NEOGEN 3Q REV. $95.9M, EST. $97.9M; 22/03/2018 – NEOGEN CORP NEOG.O : CRAIG-HALLUM RAISES TARGET PRICE TO $65 FROM $63; RATING HOLD; 20/04/2018 – DJ Neogen Corporation, Inst Holders, 1Q 2018 (NEOG); 06/04/2018 – Jerome Hagedorn Named Neogen VP of Food Safety Ops; 06/04/2018 – Hagedorn named Neogen VP of food safety operations; 22/03/2018 – Neogen 3Q Rev $95.9M; 22/03/2018 – Neogen 3Q EPS 32c

Among 8 analysts covering CDK Global (NASDAQ:CDK), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. CDK Global had 17 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of CDK Global, Inc. (NASDAQ:CDK) has “Underweight” rating given on Friday, August 14 by JP Morgan. JP Morgan maintained the stock with “Underweight” rating in Tuesday, December 15 report. The firm has “Buy” rating by Oppenheimer given on Wednesday, August 9. The rating was upgraded by Barrington Research on Tuesday, May 29 to “Outperform”. The company was downgraded on Wednesday, January 17 by Barrington Research. The rating was upgraded by Wells Fargo on Wednesday, June 21 to “Outperform”. The stock has “Neutral” rating by JP Morgan on Wednesday, April 6. Morgan Stanley maintained CDK Global, Inc. (NASDAQ:CDK) on Friday, April 27 with “Equal-Weight” rating. The stock has “Outperform” rating by Barrington Research on Thursday, February 4. The stock has “Buy” rating by Wells Fargo on Wednesday, January 31.

Analysts await CDK Global, Inc. (NASDAQ:CDK) to report earnings on August, 7. They expect $0.82 EPS, up 49.09% or $0.27 from last year’s $0.55 per share. CDK’s profit will be $107.92 million for 19.50 P/E if the $0.82 EPS becomes a reality. After $0.85 actual EPS reported by CDK Global, Inc. for the previous quarter, Wall Street now forecasts -3.53% negative EPS growth.

More news for CDK Global, Inc. (NASDAQ:CDK) were recently published by: Nasdaq.com, which released: “CDK Global Announces Pricing of its $500000000 5.875% Senior Notes Due 2026” on June 04, 2018. Globenewswire.com‘s article titled: “CDK Global Announces Proposed Registered Offering of Senior Notes” and published on June 04, 2018 is yet another important article.

Investors sentiment increased to 6.71 in 2018 Q1. Its up 5.22, from 1.49 in 2017Q4. It is positive, as 13 investors sold NEOG shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported. Blackrock has invested 0.02% in Neogen Corporation (NASDAQ:NEOG). Royal Bank Of Canada owns 861,785 shares or 0.03% of their US portfolio. Aqr Capital Limited Co holds 0% or 4,047 shares. Pub Employees Retirement Association Of Colorado holds 0.16% or 352,288 shares in its portfolio. Timber Creek Cap Management Limited Liability Corp reported 433 shares or 0.02% of all its holdings. Creative Planning holds 0% or 7,294 shares in its portfolio. Comerica Bancshares, a Michigan-based fund reported 88,982 shares. 46 were reported by Smithfield Tru. Alliancebernstein LP holds 117,451 shares. Ameriprise Fincl Inc holds 0.02% or 545,551 shares in its portfolio. Aperio Gru Limited Com invested 0.01% of its portfolio in Neogen Corporation (NASDAQ:NEOG). Pub Sector Pension Board reported 33,365 shares stake. Thomson Horstmann Bryant owns 0.25% invested in Neogen Corporation (NASDAQ:NEOG) for 28,095 shares. State Street Corporation invested in 0.01% or 1.36 million shares. Gemmer Asset Management Limited Liability Co has invested 0% in Neogen Corporation (NASDAQ:NEOG).

Among 5 analysts covering Neogen (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Neogen had 7 analyst reports since August 26, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, January 4 by Roth Capital. The stock has “Buy” rating by Zacks on Wednesday, August 26. The firm has “Hold” rating by Craig Hallum given on Tuesday, December 22. The stock has “Hold” rating by Stephens on Monday, March 26. Zacks downgraded the stock to “Hold” rating in Tuesday, September 22 report.

Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.